Usa India covid-19 information Usa India

USFDA nod for Sun Pharma Halol plant products may be put on hold

Reading now: 532
www.livemint.com

USFDA approvals for products manufactured at Sun Pharmaceutical Industries’ Halol plant in Gujarat may be put on hold after the regulator placed it under ‘official action indicated’, the company informed the stock exchanges on Sunday.

With this, a risk of the US FDA issuing the company a warning letter exists. The regulator expects the Dilipn Shanghvi company to take corrective action at the plant.

US supplies from Halol, as of now, contribute approximately 3-4% of Sun’s consolidated revenues. The dependence of the company’s on the plant for its exports to the US has come down over the years. “In their communication, the USFDA has mentioned that they may put all new approvals from the Halol facility on hold.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA